FDA, USPTO Data Show Earlier Small-Molecule Drug Patenting
The Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, had a monumental impact on competition between branded and generic small-molecule pharmaceuticals.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article